GlassScriptPhysician profile
Michelle L Orr
NPI 1598769291
$5,378.47
in general payments reported to CMS, 2019-2025
38 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $411 · 2021: $747 · 2022: $496 · 2023: $817 · 2024: $1,132 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,809 · Education: $23.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,809.26 |
| Education | $23.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $603.92 | 2019-2025 | Rybelsus, Ozempic, Sogroya |
| Lilly USA, LLC | $600.44 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $596.33 | 2019-2025 | Jardiance |
| Abbott Laboratories | $545.71 | 2020-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $373.42 | 2019-2023 | Farxiga |
| Amgen INC. | $286.76 | 2019-2025 | Tepezza, Repatha, Evenity |
| Sanofi-Aventis U.S. LLC | $257.28 | 2019-2024 | |
| Radius Health, INC. | $245.99 | 2023-2025 | Tymlos |
| Amarin Pharma, INC. | $222.15 | 2019-2021 | |
| Dexcom, INC. | $212.50 | 2019-2024 | Dexcom G6 Transmitter |
| Cequr Corporation | $126.75 | 2023-2025 | Cequr Simplicity |
| Insulet Corporation | $109.96 | 2020-2025 | Omnipod |
| Ascensia Diabetes Care US INC. | $108.38 | 2021-2025 | |
| Pfizer INC. | $103.82 | 2019-2025 | |
| Abbvie INC. | $88.62 | 2019-2023 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.